Less than five per cent of adults with overactive bladder currently treated with drug therapies: GlobalData Read more
Zydus Cadila Desidustat’s better positioned to get first-to-market advantage within HIF-PHI class in India, says GlobalData Read more
AI, big data will continue to disrupt pharma sector, say healthcare industry professionals in GlobalData survey Read more
Microbiome-targeting treatment is set to evolve, address multiple immunological indications: GlobalData Read more
Sales of long-acting immunosuppressants for non-infectious uveitis to touch $357 mn by 2029: GlobalData Read more